在脏疾病中的骨质疏松症
1Department of Nephrology, Goa Medical College, Bambolim, Goa 403202 India.
Indian journal of orthopaedics
|December 18, 2023
概括
骨质疏松症是一种骨质减少和骨折风险增加的疾病,在慢性病 (CKD) 中很常见. 对于CKD患者的骨质疏松症的管理策略因疾病阶段而异,重点是骨折预防.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 骨质疏松症的特点是骨质量减少和骨折风险增加.
- 慢性病 (CKD) 与各种骨代谢障碍有关,包括骨质疏松症.
- 骨质疏松症在CKD早期阶段普遍存在,并在晚期与骨质疏松症共存.
研究的目的:
- 要总结骨质疏松症和慢性病之间的关系.
- 概述CKD患者骨质疏松症的风险因素,诊断标准和管理原则.
主要方法:
- 关于骨质疏松症和CKD的文献综述.
- 诊断方法的分析,包括骨矿物质密度 (BMD) 的评估和CKD-矿物质骨障碍 (CKD-MBD) 的排除.
- 基于CKD阶段的治疗变化的检查.
主要成果:
- 在CKD患者中,骨质疏松症的患病率显著.
- 诊断需要BMD评估,CKD-MBD排除,骨折史和实验室测试.
- 早期CKD阶段的骨质疏松症治疗 (1-3) 与一般人群的指导方针相一致,重点是骨折预防.
结论:
- 骨质疏松症是慢性病患者的一个重大问题.
- 一种全面的诊断方法对于在CKD中准确诊断骨质疏松症至关重要.
- 量身定制的管理策略,优先考虑骨折预防,对于CKD骨质疏松症至关重要.
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Renal Regulation of Acid-Base Balance
460
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
460
Renal Drug Excretion: Tubular Secretion
192
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
192


